Alovudine

Alovudine
Clinical data
Other names	Fluorothymidine
ATC code	none;
Identifiers
CAS Number	25526-93-6 ;
PubChem CID	33039;
ChemSpider	30578 ;
UNII	PG53R0DWDQ;
KEGG	D02830 ;
ChEMBL	ChEMBL105318 ;
CompTox Dashboard (EPA)	DTXSID4046579 ;
Chemical and physical data
Formula	C10H13FN2O4
Molar mass	244.222 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C/1NC(=O)N(\C=C\1C)[C@@H]2O[C@@H]([C@@H](F)C2)CO;
	InChI InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1 ; Key:UXCAQJAQSWSNPQ-XLPZGREQSA-N ;
	(what is this?) (verify)

Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.^[1]

References

^ Georgopapadakou N (January 2007). "Discontinued drugs in 2005: anti-infectives". Expert Opinion on Investigational Drugs. 16 (1): 1–10. doi:10.1517/13543784.16.1.1. PMID 17155849. S2CID 24703317.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

[1] Georgopapadakou N (January 2007). "Discontinued drugs in 2005: anti-infectives". Expert Opinion on Investigational Drugs. 16 (1): 1–10. doi:10.1517/13543784.16.1.1. PMID 17155849. S2CID 24703317.

[1]

See also

References